Key points from article :
Theranautilus, a deep-tech startup incubated at the Indian Institute of Science (IISc), has raised $1.2 million in a seed funding round led by Pi Ventures. The startup specializes in developing nanorobotic solutions for healthcare, with a primary focus on treating dental hypersensitivity. This condition affects millions globally, causing discomfort when consuming hot, cold, or sweet foods.
The innovative technology designed by Theranautilus involves nanorobots that can navigate dental tissues to deliver biocompatible materials, targeting and addressing hypersensitivity at its root cause. These nanorobots, engineered for precision, ensure effective and localized treatment, potentially transforming dental care practices.
The funds will be used to establish an ISO-certified manufacturing facility to produce nanorobots at an industrial scale. This is a critical step toward initiating clinical trials, gaining regulatory approvals, and eventually commercializing the product. The startup also plans to file new international patents to secure its intellectual property and maintain a competitive edge in the market.
Founded in 2020, the company envisions revolutionizing dental care through cutting-edge nanotechnology. Their work bridges science and healthcare, offering a potential solution to an issue that affects a large portion of the population.
Theranautilus’s achievements highlight the growing role of deep-tech startups in addressing real-world problems. By combining advanced research with practical applications, the team seeks to make dental care more effective and accessible. The funding will enable them to move closer to realizing their vision, marking a significant milestone for both the company and the field of nanotechnology in healthcare.
